Human serum complement c3 and factor h in the syndrome of hemolysis, elevated liver enzymes, and low platelet count

American Journal of Reproductive Immunology

Volumn 62, Issue 4, 2009, Pages 238-242

  Ari, Elif ^a   Yilmaz, Yusuf ^a   Gul, Ahmet ^b   Alahdab, Yesim Ozen ^a   Kedrah, Alla Eldeen ^a   Macunluoglu, Beyza ^a   Aydin, Atakan ^a   Arikan, Hakki ^a   Ozener, Cetin ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Istanbul Bakirkoy Women and Children Hospital   (Turkey)

Author keywords

Complement; Factor H; HELLP syndrome; Pre eclampsia

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; HELLP SYNDROME; HUMAN; PATHOGENESIS; PREECLAMPSIA; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; THROMBOCYTE COUNT;

ADULT; BLOOD PLATELETS; COMPLEMENT C3; COMPLEMENT FACTOR H; FEMALE; HELLP SYNDROME; HEMOLYSIS; HUMANS; LIVER; PRE-ECLAMPSIA; PREGNANCY;

EID: 70349978795     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00731.x     Document Type: Article

References (14)

1. Haram K, Svendsen E, Abildgaard U. The HELLP syndrome: clinical issues and management. A review. BMC Pregnancy Childbirth 2009, 9:8.
2. Barton JR, Sibai BM. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 2004, 31:807-833.
3. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004, 103:981-991.
4. Fang CJ, Richards A, Liszewski MK, Kavanagh D, Atkinson JP. Advances in understanding of pathogenesis of aHUS and HELLP. Br J Haematol 2008, 143:336-348.
5. Feinberg BB. Preeclampsia: the death of Goliath. Am J Reprod Immunol 2006, 55:84-98.
6. Fakhouri F, Jablonski M, Lepercq J, Blouin J, Benachi A, Hourmant M, Pirson Y, Dürrbach A, Grünfeld JP, Knebelmann B, Frémeaux-Bacchi V. Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome. Blood 2008, 112:4542-4545.
7. Kirschfink M. Controlling the complement system in inflammation. Immunopharmacology 1997, 38:51-62.
8. Józsi M, Zipfel PF. Factor H family proteins and human diseases. Trends Immunol 2008, 29:380-387.
9. Haeger M, Unander M, Bengtsson A. Enhanced anaphylatoxin and terminal C5b-9 complement complex formation in patients with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 1990, 76:698-702.
10. Haeger M, Unander M, Bengtsson A. Complement activation in relation to development of preeclampsia. Obstet Gynecol 1991, 78:46-49.
11. Boenig G, Euler HH, Wulf H. Precipitable C4-poor immune complexes in HELLP syndrome and pre-eclampsia. Z Geburtshilfe Perinatol 1991, 195:254-259.
12. Molvarec A, Prohászka Z, Nagy B, Kalabay L, Szalay J, Füst G, Karádi I, Rigó J. Association of increased serum heat shock protein 70 and C-reactive protein concentrations and decreased serum alpha(2)-HS glycoprotein concentration with the syndrome of hemolysis, elevated liver enzymes, and low platelet count. J Reprod Immunol 2007, 73:172-179.
13. Atkinson JP, Goodship TH. Complement factor H and the hemolytic uremic syndrome. J Exp Med 2007, 204:1245-1248.
14. Mnjoyan Z, Li J, Afshar-Kharghan V. Factor H binds to platelet integrin alphaIIbbeta3. Platelets 2008, 19:512-519.